nodes	percent_of_prediction	percent_of_DWPC	metapath
Tafluprost—PTGS2—ulcerative colitis	0.364	1	CbGaD
Tafluprost—PTGS2—Olsalazine—ulcerative colitis	0.142	0.254	CbGbCtD
Tafluprost—PTGS2—Balsalazide—ulcerative colitis	0.127	0.226	CbGbCtD
Tafluprost—PTGS2—Mesalazine—ulcerative colitis	0.101	0.181	CbGbCtD
Tafluprost—PTGS2—Sulfasalazine—ulcerative colitis	0.0566	0.101	CbGbCtD
Tafluprost—PTGS2—Triamcinolone—ulcerative colitis	0.0566	0.101	CbGbCtD
Tafluprost—PTGS2—Betamethasone—ulcerative colitis	0.0486	0.0867	CbGbCtD
Tafluprost—PTGS2—Dexamethasone—ulcerative colitis	0.0283	0.0504	CbGbCtD
Tafluprost—PTGFR—Prostanoid ligand receptors—PTGER4—ulcerative colitis	0.00471	0.0978	CbGpPWpGaD
Tafluprost—PTGFR—Eicosanoid ligand-binding receptors—PTGER4—ulcerative colitis	0.00313	0.065	CbGpPWpGaD
Tafluprost—PTGFR—Small Ligand GPCRs—PTGER4—ulcerative colitis	0.00259	0.0538	CbGpPWpGaD
Tafluprost—PTGS2—Overview of nanoparticle effects—CDH3—ulcerative colitis	0.00235	0.0487	CbGpPWpGaD
Tafluprost—PTGFR—Prostaglandin Synthesis and Regulation—PTGER4—ulcerative colitis	0.0018	0.0373	CbGpPWpGaD
Tafluprost—PTGFR—Prostaglandin Synthesis and Regulation—PTGS1—ulcerative colitis	0.00177	0.0368	CbGpPWpGaD
Tafluprost—Exacerbation of asthma—Mesalazine—ulcerative colitis	0.00177	0.073	CcSEcCtD
Tafluprost—Uveitis—Azathioprine—ulcerative colitis	0.00145	0.0599	CcSEcCtD
Tafluprost—PTGS2—Calcium signaling in the CD4+ TCR pathway—CHP1—ulcerative colitis	0.00142	0.0295	CbGpPWpGaD
Tafluprost—PTGFR—GPCRs, Class A Rhodopsin-like—GPR35—ulcerative colitis	0.00138	0.0288	CbGpPWpGaD
Tafluprost—PTGFR—GPCRs, Other—CXCR1—ulcerative colitis	0.00114	0.0237	CbGpPWpGaD
Tafluprost—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS1—ulcerative colitis	0.00106	0.0221	CbGpPWpGaD
Tafluprost—Eye irritation—Nicotine—ulcerative colitis	0.000966	0.0399	CcSEcCtD
Tafluprost—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IKZF1—ulcerative colitis	0.000964	0.02	CbGpPWpGaD
Tafluprost—Lacrimation increased—Nicotine—ulcerative colitis	0.000895	0.0369	CcSEcCtD
Tafluprost—PTGFR—GPCRs, Other—CXCR2—ulcerative colitis	0.000894	0.0186	CbGpPWpGaD
Tafluprost—PTGS2—Fluocinonide—Budesonide—ulcerative colitis	0.000894	0.247	CbGdCrCtD
Tafluprost—PTGS2—C-MYB transcription factor network—PRTN3—ulcerative colitis	0.00084	0.0175	CbGpPWpGaD
Tafluprost—PTGS2—Overview of nanoparticle effects—PTGS1—ulcerative colitis	0.000833	0.0173	CbGpPWpGaD
Tafluprost—Conjunctival hyperaemia—Prednisolone—ulcerative colitis	0.000765	0.0316	CcSEcCtD
Tafluprost—PTGS2—Eicosanoid Synthesis—PTGS1—ulcerative colitis	0.000691	0.0143	CbGpPWpGaD
Tafluprost—PTGFR—Prostaglandin Synthesis and Regulation—PTGS2—ulcerative colitis	0.000678	0.0141	CbGpPWpGaD
Tafluprost—Conjunctival hyperaemia—Dexamethasone—ulcerative colitis	0.000638	0.0263	CcSEcCtD
Tafluprost—Conjunctival hyperaemia—Betamethasone—ulcerative colitis	0.000638	0.0263	CcSEcCtD
Tafluprost—Cataract—Budesonide—ulcerative colitis	0.000597	0.0246	CcSEcCtD
Tafluprost—Endophthalmitis—Dexamethasone—ulcerative colitis	0.00059	0.0243	CcSEcCtD
Tafluprost—Endophthalmitis—Betamethasone—ulcerative colitis	0.00059	0.0243	CcSEcCtD
Tafluprost—PTGS2—Prostaglandin Synthesis and Regulation—PTGER4—ulcerative colitis	0.000587	0.0122	CbGpPWpGaD
Tafluprost—PTGS2—Prostaglandin Synthesis and Regulation—PTGS1—ulcerative colitis	0.000578	0.012	CbGpPWpGaD
Tafluprost—PTGFR—GPCRs, Other—ADRB2—ulcerative colitis	0.000561	0.0116	CbGpPWpGaD
Tafluprost—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—ulcerative colitis	0.000552	0.0115	CbGpPWpGaD
Tafluprost—Nasopharyngitis—Nicotine—ulcerative colitis	0.000535	0.0221	CcSEcCtD
Tafluprost—PTGS2—Calcium signaling in the CD4+ TCR pathway—CALM3—ulcerative colitis	0.000534	0.0111	CbGpPWpGaD
Tafluprost—Endophthalmitis—Prednisone—ulcerative colitis	0.000513	0.0212	CcSEcCtD
Tafluprost—PTGFR—GPCRs, Class A Rhodopsin-like—CXCR1—ulcerative colitis	0.000496	0.0103	CbGpPWpGaD
Tafluprost—PTGS2—Overview of nanoparticle effects—CRP—ulcerative colitis	0.000476	0.00988	CbGpPWpGaD
Tafluprost—Visual acuity reduced—Dexamethasone—ulcerative colitis	0.000472	0.0195	CcSEcCtD
Tafluprost—Visual acuity reduced—Betamethasone—ulcerative colitis	0.000472	0.0195	CcSEcCtD
Tafluprost—PTGS2—Fluocinonide—Methylprednisolone—ulcerative colitis	0.000432	0.119	CbGdCrCtD
Tafluprost—Dry eye—Mesalazine—ulcerative colitis	0.000427	0.0176	CcSEcCtD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CXCR1—ulcerative colitis	0.000425	0.00883	CbGpPWpGaD
Tafluprost—PTGS2—Fluocinonide—Dexamethasone—ulcerative colitis	0.000425	0.118	CbGdCrCtD
Tafluprost—PTGS2—Fluocinonide—Betamethasone—ulcerative colitis	0.000425	0.118	CbGdCrCtD
Tafluprost—Rhinitis—Nicotine—ulcerative colitis	0.000415	0.0171	CcSEcCtD
Tafluprost—PTGS2—Fluocinonide—Triamcinolone—ulcerative colitis	0.000415	0.115	CbGdCrCtD
Tafluprost—Eye irritation—Prednisolone—ulcerative colitis	0.000394	0.0163	CcSEcCtD
Tafluprost—PTGFR—GPCRs, Class A Rhodopsin-like—CXCR2—ulcerative colitis	0.000388	0.00807	CbGpPWpGaD
Tafluprost—PTGS2—Arachidonic acid metabolism—PTGS1—ulcerative colitis	0.000384	0.00797	CbGpPWpGaD
Tafluprost—PTGFR—G alpha (q) signalling events—GHRL—ulcerative colitis	0.000381	0.00791	CbGpPWpGaD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCL20—ulcerative colitis	0.000373	0.00775	CbGpPWpGaD
Tafluprost—Eye pain—Mesalazine—ulcerative colitis	0.000372	0.0153	CcSEcCtD
Tafluprost—Nasopharyngitis—Budesonide—ulcerative colitis	0.000369	0.0152	CcSEcCtD
Tafluprost—PTGFR—GPCRs, Class A Rhodopsin-like—CCR6—ulcerative colitis	0.000365	0.00758	CbGpPWpGaD
Tafluprost—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CALM3—ulcerative colitis	0.000346	0.00718	CbGpPWpGaD
Tafluprost—Cataract—Hydrocortisone—ulcerative colitis	0.000345	0.0142	CcSEcCtD
Tafluprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—ulcerative colitis	0.000341	0.00707	CbGpPWpGaD
Tafluprost—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—ulcerative colitis	0.000336	0.00697	CbGpPWpGaD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CXCR2—ulcerative colitis	0.000333	0.00691	CbGpPWpGaD
Tafluprost—Cataract—Triamcinolone—ulcerative colitis	0.000325	0.0134	CcSEcCtD
Tafluprost—PTGFR—GPCR ligand binding—CXCR1—ulcerative colitis	0.000324	0.00672	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—MIF—ulcerative colitis	0.000324	0.00672	CbGpPWpGaD
Tafluprost—PTGFR—GPCRs, Class A Rhodopsin-like—PTGER4—ulcerative colitis	0.000321	0.00668	CbGpPWpGaD
Tafluprost—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKB1—ulcerative colitis	0.000318	0.0066	CbGpPWpGaD
Tafluprost—Cough—Nicotine—ulcerative colitis	0.000315	0.013	CcSEcCtD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	0.000313	0.0065	CbGpPWpGaD
Tafluprost—PTGS2—Overview of nanoparticle effects—CXCL8—ulcerative colitis	0.000309	0.00643	CbGpPWpGaD
Tafluprost—Urinary tract infection—Budesonide—ulcerative colitis	0.000309	0.0127	CcSEcCtD
Tafluprost—Dry eye—Hydrocortisone—ulcerative colitis	0.000303	0.0125	CcSEcCtD
Tafluprost—Nasopharyngitis—Mesalazine—ulcerative colitis	0.0003	0.0124	CcSEcCtD
Tafluprost—Cataract—Betamethasone—ulcerative colitis	0.000295	0.0122	CcSEcCtD
Tafluprost—Cataract—Dexamethasone—ulcerative colitis	0.000295	0.0122	CcSEcCtD
Tafluprost—Asthma—Mesalazine—ulcerative colitis	0.00029	0.012	CcSEcCtD
Tafluprost—Nervous system disorder—Nicotine—ulcerative colitis	0.000289	0.0119	CcSEcCtD
Tafluprost—Rhinitis—Budesonide—ulcerative colitis	0.000286	0.0118	CcSEcCtD
Tafluprost—PTGFR—GPCR ligand binding—CCL20—ulcerative colitis	0.000284	0.0059	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—MST1—ulcerative colitis	0.000281	0.00583	CbGpPWpGaD
Tafluprost—PTGS2—C-MYB transcription factor network—MPO—ulcerative colitis	0.000275	0.00572	CbGpPWpGaD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	0.000275	0.00572	CbGpPWpGaD
Tafluprost—Eye disorder—Budesonide—ulcerative colitis	0.000267	0.011	CcSEcCtD
Tafluprost—PTGS2—Selenium Micronutrient Network—MPO—ulcerative colitis	0.000265	0.00551	CbGpPWpGaD
Tafluprost—Dyspnoea—Nicotine—ulcerative colitis	0.000262	0.0108	CcSEcCtD
Tafluprost—PTGS2—Fluticasone Propionate—Methylprednisolone—ulcerative colitis	0.000261	0.0721	CbGdCrCtD
Tafluprost—Dry eye—Dexamethasone—ulcerative colitis	0.000259	0.0107	CcSEcCtD
Tafluprost—Dry eye—Betamethasone—ulcerative colitis	0.000259	0.0107	CcSEcCtD
Tafluprost—Cataract—Prednisone—ulcerative colitis	0.000257	0.0106	CcSEcCtD
Tafluprost—PTGS2—Fluticasone Propionate—Dexamethasone—ulcerative colitis	0.000256	0.0709	CbGdCrCtD
Tafluprost—PTGS2—Fluticasone Propionate—Betamethasone—ulcerative colitis	0.000256	0.0709	CbGdCrCtD
Tafluprost—PTGFR—GPCR ligand binding—CXCR2—ulcerative colitis	0.000253	0.00526	CbGpPWpGaD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	0.000252	0.00524	CbGpPWpGaD
Tafluprost—Urinary tract infection—Mesalazine—ulcerative colitis	0.000251	0.0104	CcSEcCtD
Tafluprost—PTGS2—Fluticasone Propionate—Triamcinolone—ulcerative colitis	0.000251	0.0693	CbGdCrCtD
Tafluprost—PTGS2—Selenium Micronutrient Network—PTGS1—ulcerative colitis	0.000244	0.00507	CbGpPWpGaD
Tafluprost—PTGFR—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	0.000244	0.00506	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—CCR6—ulcerative colitis	0.000238	0.00495	CbGpPWpGaD
Tafluprost—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—ulcerative colitis	0.000237	0.00493	CbGpPWpGaD
Tafluprost—Vision blurred—Budesonide—ulcerative colitis	0.000234	0.00966	CcSEcCtD
Tafluprost—Rhinitis—Mesalazine—ulcerative colitis	0.000233	0.0096	CcSEcCtD
Tafluprost—Eye pain—Betamethasone—ulcerative colitis	0.000226	0.00931	CcSEcCtD
Tafluprost—Eye pain—Dexamethasone—ulcerative colitis	0.000226	0.00931	CcSEcCtD
Tafluprost—Eye disorder—Mesalazine—ulcerative colitis	0.000217	0.00895	CcSEcCtD
Tafluprost—Cough—Budesonide—ulcerative colitis	0.000217	0.00894	CcSEcCtD
Tafluprost—PTGS2—Overview of nanoparticle effects—TNF—ulcerative colitis	0.000215	0.00447	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—FCGR2A—ulcerative colitis	0.000213	0.00441	CbGpPWpGaD
Tafluprost—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—ulcerative colitis	0.000211	0.00438	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—PTGER4—ulcerative colitis	0.00021	0.00436	CbGpPWpGaD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	0.000209	0.00433	CbGpPWpGaD
Tafluprost—Pruritus—Nicotine—ulcerative colitis	0.000208	0.00859	CcSEcCtD
Tafluprost—Nervous system disorder—Budesonide—ulcerative colitis	0.000199	0.0082	CcSEcCtD
Tafluprost—Asthma—Triamcinolone—ulcerative colitis	0.000194	0.00801	CcSEcCtD
Tafluprost—PTGFR—GPCR ligand binding—GHRL—ulcerative colitis	0.000192	0.00399	CbGpPWpGaD
Tafluprost—Vision blurred—Mesalazine—ulcerative colitis	0.00019	0.00785	CcSEcCtD
Tafluprost—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—ulcerative colitis	0.000187	0.00388	CbGpPWpGaD
Tafluprost—Headache—Nicotine—ulcerative colitis	0.000184	0.00761	CcSEcCtD
Tafluprost—PTGFR—GPCR downstream signaling—CXCR1—ulcerative colitis	0.000183	0.0038	CbGpPWpGaD
Tafluprost—Dyspnoea—Budesonide—ulcerative colitis	0.000181	0.00746	CcSEcCtD
Tafluprost—Cough—Mesalazine—ulcerative colitis	0.000176	0.00727	CcSEcCtD
Tafluprost—PTGS2—Overview of nanoparticle effects—IL6—ulcerative colitis	0.000174	0.00361	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—CXCR1—ulcerative colitis	0.000166	0.00345	CbGpPWpGaD
Tafluprost—PTGS2—Aryl Hydrocarbon Receptor—RELA—ulcerative colitis	0.000162	0.00336	CbGpPWpGaD
Tafluprost—Nervous system disorder—Mesalazine—ulcerative colitis	0.000162	0.00667	CcSEcCtD
Tafluprost—PTGFR—GPCR downstream signaling—CCL20—ulcerative colitis	0.000161	0.00334	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—ADRB2—ulcerative colitis	0.000159	0.0033	CbGpPWpGaD
Tafluprost—Rhinitis—Triamcinolone—ulcerative colitis	0.000156	0.00643	CcSEcCtD
Tafluprost—Rhinitis—Methylprednisolone—ulcerative colitis	0.000155	0.00641	CcSEcCtD
Tafluprost—Eye disorder—Hydrocortisone—ulcerative colitis	0.000154	0.00636	CcSEcCtD
Tafluprost—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—ulcerative colitis	0.000153	0.00319	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—GNA12—ulcerative colitis	0.000151	0.00314	CbGpPWpGaD
Tafluprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—ulcerative colitis	0.000149	0.0031	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—HNF4A—ulcerative colitis	0.000147	0.00306	CbGpPWpGaD
Tafluprost—Dyspnoea—Mesalazine—ulcerative colitis	0.000147	0.00606	CcSEcCtD
Tafluprost—PTGFR—Signaling by GPCR—CCL20—ulcerative colitis	0.000146	0.00303	CbGpPWpGaD
Tafluprost—Eye disorder—Methylprednisolone—ulcerative colitis	0.000145	0.00598	CcSEcCtD
Tafluprost—Pruritus—Budesonide—ulcerative colitis	0.000143	0.00592	CcSEcCtD
Tafluprost—PTGFR—GPCR downstream signaling—CXCR2—ulcerative colitis	0.000143	0.00297	CbGpPWpGaD
Tafluprost—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—ulcerative colitis	0.000143	0.00296	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—CRP—ulcerative colitis	0.00014	0.0029	CbGpPWpGaD
Tafluprost—Vision blurred—Prednisolone—ulcerative colitis	0.000139	0.00572	CcSEcCtD
Tafluprost—PTGFR—Signaling by GPCR—GNA12—ulcerative colitis	0.000137	0.00285	CbGpPWpGaD
Tafluprost—PTGS2—Aryl Hydrocarbon Receptor—NFKB1—ulcerative colitis	0.000136	0.00283	CbGpPWpGaD
Tafluprost—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—ulcerative colitis	0.000136	0.00283	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—CCR6—ulcerative colitis	0.000135	0.0028	CbGpPWpGaD
Tafluprost—Eye disorder—Dexamethasone—ulcerative colitis	0.000132	0.00544	CcSEcCtD
Tafluprost—Eye disorder—Betamethasone—ulcerative colitis	0.000132	0.00544	CcSEcCtD
Tafluprost—PTGFR—Signaling by GPCR—CXCR2—ulcerative colitis	0.00013	0.0027	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—ICAM1—ulcerative colitis	0.000128	0.00266	CbGpPWpGaD
Tafluprost—Headache—Budesonide—ulcerative colitis	0.000127	0.00524	CcSEcCtD
Tafluprost—PTGFR—Signaling by GPCR—CCR6—ulcerative colitis	0.000122	0.00254	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—SEL1L—ulcerative colitis	0.000119	0.00248	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—PTGER4—ulcerative colitis	0.000119	0.00246	CbGpPWpGaD
Tafluprost—Cough—Triamcinolone—ulcerative colitis	0.000118	0.00487	CcSEcCtD
Tafluprost—Pruritus—Mesalazine—ulcerative colitis	0.000117	0.00481	CcSEcCtD
Tafluprost—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—ulcerative colitis	0.000116	0.00242	CbGpPWpGaD
Tafluprost—Nervous system disorder—Hydrocortisone—ulcerative colitis	0.000115	0.00474	CcSEcCtD
Tafluprost—Eye disorder—Prednisone—ulcerative colitis	0.000115	0.00473	CcSEcCtD
Tafluprost—Headache—Azathioprine—ulcerative colitis	0.000113	0.00468	CcSEcCtD
Tafluprost—PTGFR—GPCR downstream signaling—GHRL—ulcerative colitis	0.000109	0.00225	CbGpPWpGaD
Tafluprost—Nervous system disorder—Methylprednisolone—ulcerative colitis	0.000108	0.00446	CcSEcCtD
Tafluprost—PTGFR—Signaling by GPCR—PTGER4—ulcerative colitis	0.000108	0.00224	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—ALB—ulcerative colitis	0.000107	0.00222	CbGpPWpGaD
Tafluprost—PTGS2—Aryl Hydrocarbon Receptor—TNF—ulcerative colitis	0.000106	0.00221	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—TLR4—ulcerative colitis	0.000106	0.0022	CbGpPWpGaD
Tafluprost—Headache—Mesalazine—ulcerative colitis	0.000103	0.00426	CcSEcCtD
Tafluprost—PTGS2—Spinal Cord Injury—ICAM1—ulcerative colitis	0.000101	0.00211	CbGpPWpGaD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	0.000101	0.00209	CbGpPWpGaD
Tafluprost—Vision blurred—Prednisone—ulcerative colitis	0.000101	0.00416	CcSEcCtD
Tafluprost—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—ulcerative colitis	9.93e-05	0.00206	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—GHRL—ulcerative colitis	9.85e-05	0.00205	CbGpPWpGaD
Tafluprost—Dyspnoea—Triamcinolone—ulcerative colitis	9.84e-05	0.00406	CcSEcCtD
Tafluprost—Nervous system disorder—Betamethasone—ulcerative colitis	9.82e-05	0.00405	CcSEcCtD
Tafluprost—Nervous system disorder—Dexamethasone—ulcerative colitis	9.82e-05	0.00405	CcSEcCtD
Tafluprost—PTGFR—Signaling Pathways—CXCR1—ulcerative colitis	9.82e-05	0.00204	CbGpPWpGaD
Tafluprost—PTGS2—C-MYB transcription factor network—CD4—ulcerative colitis	9.79e-05	0.00203	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—IFNG—ulcerative colitis	9.76e-05	0.00203	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—RELA—ulcerative colitis	9.63e-05	0.002	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—CALM3—ulcerative colitis	9.54e-05	0.00198	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—ulcerative colitis	9.2e-05	0.00191	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—ADRB2—ulcerative colitis	8.98e-05	0.00187	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—IL1B—ulcerative colitis	8.71e-05	0.00181	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CCL20—ulcerative colitis	8.62e-05	0.00179	CbGpPWpGaD
Tafluprost—Nervous system disorder—Prednisone—ulcerative colitis	8.55e-05	0.00353	CcSEcCtD
Tafluprost—Pruritus—Hydrocortisone—ulcerative colitis	8.29e-05	0.00342	CcSEcCtD
Tafluprost—PTGFR—Signaling by GPCR—ADRB2—ulcerative colitis	8.16e-05	0.00169	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—NFKB1—ulcerative colitis	8.12e-05	0.00169	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—GNA12—ulcerative colitis	8.1e-05	0.00168	CbGpPWpGaD
Tafluprost—Pruritus—Triamcinolone—ulcerative colitis	7.81e-05	0.00322	CcSEcCtD
Tafluprost—Pruritus—Methylprednisolone—ulcerative colitis	7.79e-05	0.00322	CcSEcCtD
Tafluprost—PTGS2—Spinal Cord Injury—IFNG—ulcerative colitis	7.72e-05	0.0016	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CXCR2—ulcerative colitis	7.68e-05	0.0016	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—CXCL8—ulcerative colitis	7.68e-05	0.00159	CbGpPWpGaD
Tafluprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	7.65e-05	0.00159	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—ADCY5—ulcerative colitis	7.62e-05	0.00158	CbGpPWpGaD
Tafluprost—Headache—Prednisolone—ulcerative colitis	7.52e-05	0.0031	CcSEcCtD
Tafluprost—Headache—Hydrocortisone—ulcerative colitis	7.34e-05	0.00303	CcSEcCtD
Tafluprost—PTGFR—Signaling Pathways—CCR6—ulcerative colitis	7.22e-05	0.0015	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—CXCL8—ulcerative colitis	7.18e-05	0.00149	CbGpPWpGaD
Tafluprost—Pruritus—Betamethasone—ulcerative colitis	7.09e-05	0.00292	CcSEcCtD
Tafluprost—Pruritus—Dexamethasone—ulcerative colitis	7.09e-05	0.00292	CcSEcCtD
Tafluprost—PTGS2—Disease—CHP1—ulcerative colitis	6.99e-05	0.00145	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—ADCY5—ulcerative colitis	6.92e-05	0.00144	CbGpPWpGaD
Tafluprost—Headache—Triamcinolone—ulcerative colitis	6.91e-05	0.00285	CcSEcCtD
Tafluprost—Headache—Methylprednisolone—ulcerative colitis	6.9e-05	0.00285	CcSEcCtD
Tafluprost—PTGS2—Spinal Cord Injury—IL1B—ulcerative colitis	6.89e-05	0.00143	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—IL2—ulcerative colitis	6.86e-05	0.00142	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—MAML2—ulcerative colitis	6.85e-05	0.00142	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—MMP9—ulcerative colitis	6.49e-05	0.00135	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PTGER4—ulcerative colitis	6.36e-05	0.00132	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—TNF—ulcerative colitis	6.32e-05	0.00131	CbGpPWpGaD
Tafluprost—Headache—Betamethasone—ulcerative colitis	6.27e-05	0.00259	CcSEcCtD
Tafluprost—Headache—Dexamethasone—ulcerative colitis	6.27e-05	0.00259	CcSEcCtD
Tafluprost—Pruritus—Prednisone—ulcerative colitis	6.17e-05	0.00255	CcSEcCtD
Tafluprost—PTGS2—Metabolism—CHP1—ulcerative colitis	5.86e-05	0.00122	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—GHRL—ulcerative colitis	5.82e-05	0.00121	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CALM3—ulcerative colitis	5.64e-05	0.00117	CbGpPWpGaD
Tafluprost—PTGS2—Disease—SEL1L—ulcerative colitis	5.55e-05	0.00115	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—RIPK2—ulcerative colitis	5.55e-05	0.00115	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	5.49e-05	0.00114	CbGpPWpGaD
Tafluprost—Headache—Prednisone—ulcerative colitis	5.46e-05	0.00225	CcSEcCtD
Tafluprost—PTGS2—Spinal Cord Injury—TGFB1—ulcerative colitis	5.35e-05	0.00111	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—IL6—ulcerative colitis	5.1e-05	0.00106	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—DLD—ulcerative colitis	5.05e-05	0.00105	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—TNF—ulcerative colitis	5e-05	0.00104	CbGpPWpGaD
Tafluprost—PTGS2—Disease—LTF—ulcerative colitis	4.98e-05	0.00103	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—ADRB2—ulcerative colitis	4.82e-05	0.001	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—JAK2—ulcerative colitis	4.75e-05	0.000987	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—TP53—ulcerative colitis	4.41e-05	0.000915	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	4.37e-05	0.000908	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—CXCL8—ulcerative colitis	4.34e-05	0.000901	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—JAK2—ulcerative colitis	4.32e-05	0.000896	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—IL2—ulcerative colitis	4.15e-05	0.000861	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—ADCY5—ulcerative colitis	4.09e-05	0.000849	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—IL6—ulcerative colitis	4.03e-05	0.000838	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—CXCL8—ulcerative colitis	3.94e-05	0.000818	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—IL2—ulcerative colitis	3.76e-05	0.000782	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	3.64e-05	0.000756	CbGpPWpGaD
Tafluprost—PTGS2—Disease—SLC11A1—ulcerative colitis	3.55e-05	0.000737	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	3.4e-05	0.000706	CbGpPWpGaD
Tafluprost—PTGS2—Disease—MAML2—ulcerative colitis	3.19e-05	0.000663	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	3e-05	0.000622	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	2.67e-05	0.000555	CbGpPWpGaD
Tafluprost—PTGS2—Disease—CALM3—ulcerative colitis	2.63e-05	0.000546	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—JAK2—ulcerative colitis	2.55e-05	0.00053	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—RELA—ulcerative colitis	2.47e-05	0.000513	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PTGS1—ulcerative colitis	2.44e-05	0.000508	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	2.4e-05	0.000499	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CXCL8—ulcerative colitis	2.33e-05	0.000483	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—IL2—ulcerative colitis	2.22e-05	0.000462	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—IL6—ulcerative colitis	2.21e-05	0.00046	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CALM3—ulcerative colitis	2.2e-05	0.000457	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—MMP9—ulcerative colitis	2.1e-05	0.000437	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—NFKB1—ulcerative colitis	2.08e-05	0.000433	CbGpPWpGaD
Tafluprost—PTGS2—Disease—ADCY5—ulcerative colitis	1.91e-05	0.000396	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—STAT3—ulcerative colitis	1.87e-05	0.000389	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—TGFB1—ulcerative colitis	1.73e-05	0.00036	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ABCB1—ulcerative colitis	1.71e-05	0.000355	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ADCY5—ulcerative colitis	1.6e-05	0.000332	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—TP53—ulcerative colitis	1.43e-05	0.000297	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—IL6—ulcerative colitis	1.31e-05	0.000272	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PPARG—ulcerative colitis	1.19e-05	0.000247	CbGpPWpGaD
Tafluprost—PTGS2—Disease—JAK2—ulcerative colitis	1.19e-05	0.000247	CbGpPWpGaD
Tafluprost—PTGS2—Disease—CD4—ulcerative colitis	1.13e-05	0.000234	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ALB—ulcerative colitis	1.07e-05	0.000222	CbGpPWpGaD
Tafluprost—PTGS2—Disease—STAT3—ulcerative colitis	8.72e-06	0.000181	CbGpPWpGaD
Tafluprost—PTGS2—Disease—TGFB1—ulcerative colitis	8.08e-06	0.000168	CbGpPWpGaD
Tafluprost—PTGS2—Disease—IL6—ulcerative colitis	6.09e-06	0.000127	CbGpPWpGaD
